Assessing treatment pattern and cost consequence of lopinavir/ritonavir versus nelfinavir therapy in HIV patients

被引：0
|
作者：
Luo, MP [1 ]
Boggs, R [1 ]
Bernstein, B [1 ]
Sun, E [1 ]
Ashraf, T [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
117
引用
收藏
页码：L75 / L76
页数：2
相关论文
共 50 条
  • [1] Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
    Walmsley, S
    Bernstein, B
    King, M
    Arribas, J
    Beall, G
    Ruane, P
    Johnson, M
    Johnson, D
    Lalonde, R
    Japour, A
    Brun, S
    Sun, E
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26): : 2039 - 2046
  • [2] Cost effectiveness of using lopinavir/ritonavir versus nelfinavir as the first highly active antiretroviral therapy regimen for HIV infection
    Simpson, KN
    Chumney, E
    Luo, MP
    Bernstein, B
    Sun, E
    Ashraf, T
    ANTIVIRAL THERAPY, 2002, 7 (03) : L77 - L77
  • [3] Cost of therapy for ARV naive HIV-infected patients: Fosamprenavir/ritonavir versus nelfinavir
    Lee, WC
    Hoffmann, M
    Stephens, J
    Williams, K
    Liu, LZ
    Pashos, CL
    VALUE IN HEALTH, 2005, 8 (03) : 313 - 313
  • [4] Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection
    Simpson, KN
    Luo, MP
    Chumney, E
    Sun, E
    Brun, S
    Ashraf, T
    HIV CLINICAL TRIALS, 2004, 5 (05): : 294 - 304
  • [5] Cost-effectiveness of lopinavir/ritonavir compared to nelfinavir as first-line antiretroviral therapy in treatment naive HIV patients: A managed care perspective
    Luo, MP
    Botteman, MF
    Grad, O
    Cifaldi, MA
    Ashraf, T
    VALUE IN HEALTH, 2003, 6 (03) : 265 - 265
  • [6] Cost-consequence comparison of lopinavir/ritonavir (LPV/r) vs. nelfinavir (NFV) therapy in treating antiretroviral naive hiv patients using clinical trial data
    Luo, MP
    Boggs, B
    Bernstein, B
    Sun, E
    Ashraf, T
    VALUE IN HEALTH, 2002, 5 (06) : 566 - 567
  • [7] Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
    Pulido, Federico
    Arribas, Jose R.
    Delgado, Rafael
    Cabrero, Esther
    Gonzalez-Garcia, Juan
    Perez-Elias, Maria J.
    Arranz, Alberto
    Portilla, Joaquin
    Pasquau, Juan
    Iribarren, Jose A.
    Rubio, Rafael
    Norton, Michael
    AIDS, 2008, 22 (02) : F1 - F9
  • [8] Lopinavir/r versus nelfinavir as salvage therapy
    Resino, S
    Alvaro-Meca, A
    de José, MI
    Gurbindo, MD
    Ramos, JT
    Martin-Fontelos, P
    Muñoz-Fernández, MA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (04) : 392 - 393
  • [9] Evaluation of diarrhoea in patients after substitution of nelfinavir with lopinavir/ritonavir
    Bargman, E
    Rode, R
    Green, SL
    Rodwick, BM
    Eng, R
    Hara, GL
    Gargalianos-Kakolyri, P
    Boix, V
    Shen, Y
    Luo, MP
    Sylte, J
    Tressler, R
    ANTIVIRAL THERAPY, 2003, 8 (04) : L70 - L71
  • [10] Cost-effectiveness studies in HIV treatment with lopinavir/ritonavir: a review
    Codella, Paola
    Coretti, Silvia
    Fiore, Alessandra
    Rizzardini, Giuliano
    Ruggeri, Matteo
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2014, 1 (02) : 59 - 64
12345